These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6197180)

  • 1. Developmental activation of the H-2K gene is correlated with an increase in DNA methylation.
    Tanaka K; Appella E; Jay G
    Cell; 1983 Dec; 35(2 Pt 1):457-65. PubMed ID: 6197180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of alpha-fetoprotein synthesis in differentiating F9 teratocarcinoma cells is accompanied by a genome-wide loss of DNA methylation.
    Young PR; Tilghman SM
    Mol Cell Biol; 1984 May; 4(5):898-907. PubMed ID: 6203029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth conditions of F9 embryonal carcinoma cells affect the degree of DNA methylation.
    Erickson RP; Ferrucci S; Rahe B; Rosenberg MP; Morello D
    Mol Biol Rep; 1984 Dec; 10(2):109-13. PubMed ID: 6098808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exemption of satellite DNA from demethylation in immortalized differentiated derivatives of F9 mouse embryonal carcinoma cells.
    Teubner B; Schulz WA
    Exp Cell Res; 1994 Feb; 210(2):192-200. PubMed ID: 7507850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids.
    Gmür R; Solter D; Knowles BB
    J Exp Med; 1980 Jun; 151(6):1349-59. PubMed ID: 7381363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of class I H-2K, H-2D antigens on GR9 methylcholanthrene-induced tumour cell clones is related to the level of DNA methylation.
    Bonal FJ; Pareja E; Martin J; Romero C; Garrido F
    J Immunogenet; 1986; 13(2-3):179-86. PubMed ID: 2434572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated expression of an introduced MHC H-2K bm1 gene in murine embryonal carcinoma cells.
    Rosenthal A; Wright S; Cedar H; Flavell R; Grosveld F
    Nature; 1984 Aug 2-8; 310(5976):415-8. PubMed ID: 6379467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells.
    Croce CM; Linnenbach A; Huebner K; Parnes JR; Margulies DH; Appella E; Seidman JG
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5754-8. PubMed ID: 6170985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular loss variants of the murine major histocompatibility complex: nonexpression of H-2K antigens associated with marked reduction in H-2K mRNA as determined by oligonucleotide hybridization analysis.
    Zeff RA; Geier SS; Nathenson SG
    J Immunol; 1986 Aug; 137(4):1366-70. PubMed ID: 3734458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of the cDNAs corresponding to mRNAs abundant in undifferentiated mouse embryonal teratocarcinoma stem cells, but not in differentiated mouse parietal endoderm cells.
    Ikuma S; Kiyota M; Setoyama C; Shimada K
    J Biochem; 1986 Nov; 100(5):1185-92. PubMed ID: 2434467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential transcriptional control of the H-2K and H-2D loci of the major histocompatibility complex in fibrosarcoma cells.
    Aboud M; Amitai H; Huleihel M; Har-vardi I; Gopas J; Segal S
    Immunol Invest; 1991; 20(5-6):475-85. PubMed ID: 1724230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells.
    Wan YJ; Orrison BM; Lieberman R; Lazarovici P; Ozato K
    J Cell Physiol; 1987 Feb; 130(2):276-83. PubMed ID: 3102507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.
    Flanagan JR; Murata M; Burke PA; Shirayoshi Y; Appella E; Sharp PA; Ozato K
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3145-9. PubMed ID: 2014233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and secretion of beta-nerve growth factor by mouse teratocarcinoma cell lines.
    Dicou E; Houlgatte R; Brachet P
    Exp Cell Res; 1986 Dec; 167(2):287-94. PubMed ID: 3770091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A putative transmembrane protein with histidine-rich charge clusters encoded in the H-2K/tw5 region of mice.
    St-Jacques B; Han TH; MacMurray A; Shin HS
    Mol Cell Biol; 1990 Jan; 10(1):138-45. PubMed ID: 2294398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential H-2 antigen expression in teratocarcinoma-fibroblast hybrids.
    Sionov RV; Gallily R
    Exp Clin Immunogenet; 1995; 12(4):238-44. PubMed ID: 8919356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of two mouse cell lines is associated with hypomethylation of their genomes.
    Bestor TH; Hellewell SB; Ingram VM
    Mol Cell Biol; 1984 Sep; 4(9):1800-6. PubMed ID: 6092940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro.
    Razin A; Webb C; Szyf M; Yisraeli J; Rosenthal A; Naveh-Many T; Sciaky-Gallili N; Cedar H
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2275-9. PubMed ID: 6585800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.